Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Rose

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Kidney International|April 14, 1999
A laboratory model of toxin-induced hemolytic uremic syndromeC M Taylor, J M Williams, C J Lote, et al.
Journal of Clinical Pathology|December 1, 1993
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for HaematologyB T Colvin, S J Machin, T W Barrowcliffe, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent mannerK Xia, N K Mukhopadhyay, R C Inhorn, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Kidney International|April 14, 1999
A laboratory model of toxin-induced hemolytic uremic syndromeC M Taylor, J M Williams, C J Lote, et al.
Journal of Clinical Pathology|December 1, 1993
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for HaematologyB T Colvin, S J Machin, T W Barrowcliffe, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent mannerK Xia, N K Mukhopadhyay, R C Inhorn, et al.
Pageof 7